My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life
Launched by NORTHWESTERN UNIVERSITY · May 6, 2022
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
The clinical trial titled "My Wellbeing Guide" is studying a new online tool designed to help cancer patients manage stress and improve their quality of life. It focuses on reducing symptoms of depression in patients diagnosed with cancer who are receiving care at Northwestern Medicine and the University of Miami Health System. The program includes engaging animated videos, interactive activities, and written content based on cognitive behavioral therapy techniques. Participants will use this online application for seven weeks, and their progress will be tracked through assessments at the start, after the program, and again at six and twelve months later.
To join the study, participants must be at least 18 years old, have a confirmed diagnosis of cancer, and show signs of depression. They should also have internet access and be willing to participate. Those in the trial will be randomly assigned to either use the My Wellbeing Guide or a control application that offers links to helpful cancer resources. This study aims to see how effective the My Wellbeing Guide is in improving mental health for cancer patients, ensuring that all participants have access to support and information throughout the process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • a) having been reached out to by the study team for recruitment; (b) planned treatment and follow-up within the NM or UHealth healthcare system; (c) ≥ 18 years of age; (d) medical chart confirmed diagnosis of a solid or hematological malignancy; (e) elevated depressive symptoms on the PROMIS CAT (score \> or = 55) within the last 3 months; (f) access to the internet; (g) willingness to be randomized; (h) able to read English or Spanish; (i) patients must have signed informed consent prior to registration on study
- Exclusion Criteria:
- • Note: The investigators will not include any vulnerable populations in this study.
About Northwestern University
Northwestern University is a prestigious academic institution renowned for its commitment to advancing medical research and improving patient care through innovative clinical trials. With a robust infrastructure that supports interdisciplinary collaboration, Northwestern leverages its expertise in various fields, including medicine, engineering, and social sciences, to drive groundbreaking studies. The university is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring that all clinical trials are conducted with the utmost integrity and focus on participant safety. Through its Clinical Trials Office, Northwestern aims to translate scientific discoveries into effective therapies, ultimately enhancing health outcomes and contributing to the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Betina Yanez, PhD
Principal Investigator
Northwestern University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials